These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32757485)

  • 1. Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta-blockers.
    Varian KD; Ji X; Grodin JL; Verbrugge FH; Milinovich A; Kattan MW; Tang WHW
    ESC Heart Fail; 2020 Oct; 7(5):3049-3058. PubMed ID: 32757485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.
    Ibrahim NE; Gaggin HK; Turchin A; Patel HK; Song Y; Trebnick A; Doros G; Maya JF; Cannon CP; Januzzi JL
    Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):3-11. PubMed ID: 29490032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate reduction and exercise performance in recent onset heart failure with reduced ejection fraction: arguments for beta-blocker hypo-response.
    Verbrugge FH; Vrijsen J; Vercammen J; Grieten L; Dupont M; Mullens W
    Acta Cardiol; 2015 Oct; 70(5):565-72. PubMed ID: 26567816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.
    DeVore AD; Mi X; Mentz RJ; Fonarow GC; Van Dyke MK; Maya JF; Hardy NC; Hammill BG; Hernandez AF
    Am Heart J; 2016 Mar; 173():172-8. PubMed ID: 26920611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
    Loop MS; van Dyke MK; Chen L; Safford MM; Kilgore ML; Brown TM; Durant RW; Levitan EB
    J Card Fail; 2019 May; 25(5):343-351. PubMed ID: 30339796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
    Lam PH; Gupta N; Dooley DJ; Singh S; Deedwania P; Zile MR; Bhatt DL; Morgan CJ; Pitt B; Fonarow GC; Ahmed A
    Am J Med; 2018 Dec; 131(12):1473-1481. PubMed ID: 30076815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker target dosing and tolerability in a dedicated heart failure clinic in Johannesburg.
    Bolon J; McCutcheon K; Klug E; Smith D; Manga P
    Cardiovasc J Afr; 2019 Mar/Apr 23; 30(2):103-107. PubMed ID: 30740613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy.
    Corletto A; Fröhlich H; Täger T; Hochadel M; Zahn R; Kilkowski C; Winkler R; Senges J; Katus HA; Frankenstein L
    Clin Res Cardiol; 2018 Nov; 107(11):1040-1049. PubMed ID: 29774407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on Mortality of Higher Versus Lower β-Blocker (Metoprolol Succinate or Carvedilol) Dose in Patients With Heart Failure.
    Ajam T; Ajam S; Devaraj S; Fudim M; Kamalesh M
    Am J Cardiol; 2018 Sep; 122(6):994-998. PubMed ID: 30049457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
    Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
    JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?
    Franke J; Wolter JS; Meme L; Keppler J; Tschierschke R; Katus HA; Zugck C
    Clin Res Cardiol; 2013 Jan; 102(1):23-31. PubMed ID: 22760479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
    Paolillo S; Mapelli M; Bonomi A; Corrà U; Piepoli M; Veglia F; Salvioni E; Gentile P; Lagioia R; Metra M; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Carubelli V; Scrutino D; Badagliacca R; Raimondo R; Emdin M; Magrì D; Correale M; Parati G; Caravita S; Spadafora E; Re F; Cicoira M; Frigerio M; Bussotti M; Minà C; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Di Lenarda A; Passino C; Sciomer S; Iorio A; Zambon E; Guazzi M; Pacileo G; Ricci R; Contini M; Apostolo A; Palermo P; Clemenza F; Marchese G; Binno S; Lombardi C; Passantino A; Perrone Filardi P; Agostoni P
    Eur J Heart Fail; 2017 Jul; 19(7):904-914. PubMed ID: 28233458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
    Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of pulse rate with outcomes in heart failure with reduced ejection fraction: a retrospective cohort study.
    Kurgansky KE; Schubert P; Parker R; Djousse L; Riebman JB; Gagnon DR; Joseph J
    BMC Cardiovasc Disord; 2020 Feb; 20(1):92. PubMed ID: 32101141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trend of clinical outcome and surrogate markers during titration of β-blocker in heart failure patients with reduced ejection fraction: relevance of achieved heart rate and β-blocker dose.
    Kato N; Kinugawa K; Imamura T; Muraoka H; Minatsuki S; Inaba T; Maki H; Shiga T; Hatano M; Yao A; Komuro I; Nagai R
    Circ J; 2013; 77(4):1001-8. PubMed ID: 23258250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of heart rate at discharge in acute decompensation of heart failure with reduced ejection fraction.
    Bahouth F; Elias A; Ghersin I; Khoury E; Bar O; Sholy H; Khoury J; Azzam ZS
    ESC Heart Fail; 2022 Feb; 9(1):585-594. PubMed ID: 34821080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.